{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:24:41Z","timestamp":1791915881410,"version":"4.3.4"},"reference-count":84,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.jaad.2005.10.004","type":"journal-article","created":{"date-parts":[[2006,1,27]],"date-time":"2006-01-27T10:34:01Z","timestamp":1138358041000},"page":"258-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":606,"title":["Tetracyclines: Nonantibiotic properties and their clinical implications"],"prefix":"10.1016","volume":"54","author":[{"given":"Allen N.","family":"Sapadin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Fleischmajer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2005.10.004_bib1","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1021\/ja01642a064","article-title":"The structure of aureomycin","volume":"76","author":"Stephens","year":"1954","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.jaad.2005.10.004_bib2","first-page":"80","article-title":"Host modulation with tetracyclines and their chemically modified analogues","volume":"2","author":"Golub","year":"1992","journal-title":"Curr Opin Dent"},{"key":"10.1016\/j.jaad.2005.10.004_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/08959374980120011901","article-title":"Chemical and biological dynamics of tetracyclines","volume":"12","author":"Nelson","year":"1998","journal-title":"Adv Dent Res"},{"key":"10.1016\/j.jaad.2005.10.004_bib4","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1128\/iai.64.3.825-828.1996","article-title":"Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion","volume":"64","author":"Shapira","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.jaad.2005.10.004_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/08959374980120010501","article-title":"Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms","volume":"12","author":"Golub","year":"1998","journal-title":"Adv Dent Res"},{"key":"10.1016\/j.jaad.2005.10.004_bib6","series-title":"Antibiotics and their complexes","first-page":"19","article-title":"Tetracyclines and daunorubicin in metal ions in biological systems","author":"Martin","year":"1985"},{"key":"10.1016\/j.jaad.2005.10.004_bib7","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1021\/bi00267a041","article-title":"Characterization of chlortetracycline (aureomycin) as a calcium ionophore","volume":"21","author":"White","year":"1982","journal-title":"Biochemistry"},{"key":"10.1016\/j.jaad.2005.10.004_bib8","first-page":"443","article-title":"Inhibition of mitogen-induced human lymphocyte proliferative responses to tetracycline analogues","volume":"35","author":"Thong","year":"1979","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaad.2005.10.004_bib9","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/infdis\/129.2.110","article-title":"Effects of tetracyclines on leukotaxis","volume":"129","author":"Martin","year":"1974","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2005.10.004_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/1523-1747.ep12543487","article-title":"The effect of antimicrobial agents on leukocyte chemotaxis","volume":"70","author":"Esterly","year":"1978","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2005.10.004_bib11","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/brain\/awf133","article-title":"Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis","volume":"125","author":"Brundula","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.jaad.2005.10.004_bib12","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/1523-1747.ep12610281","article-title":"Anti-inflammatory effects of antimicrobial agents. An in vivo study","volume":"65","author":"Plewig","year":"1975","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2005.10.004_bib13","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/art.1780370505","article-title":"Minocycline in active rheumatoid arthritis: a double blind, placebo-controlled trial","volume":"37","author":"Kloppenburg","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2005.10.004_bib14","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/0006-2952(92)90381-R","article-title":"Inhibition of enzymatic activity of phospholipase A2 by minocycline and doxycycline","volume":"P44","author":"Pruzanski","year":"1992","journal-title":"Biochem Pharmacol"},{"issue":"Suppl 9","key":"10.1016\/j.jaad.2005.10.004_bib15","first-page":"S345","article-title":"Minocycline but not doxycycline upregulates IL-10 production in human synoviocytes, mononuclear cells and synovial explants","volume":"43","author":"Ritchlin","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2005.10.004_bib16","doi-asserted-by":"crossref","first-page":"14014","DOI":"10.1073\/pnas.93.24.14014","article-title":"A novel mechanism of action of tetracyclines: effects of nitric oxide synthases","volume":"93","author":"Amin","year":"1996","journal-title":"Proc Nat Acad Sci U S A"},{"key":"10.1016\/j.jaad.2005.10.004_bib17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0014-5793(97)00605-4","article-title":"Post-transcriptional regulation of inducible nitric oxide synthase mRNA in murine macrophages by doxycycline and chemically modified tetracyclines","volume":"410","author":"Amin","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jaad.2005.10.004_bib18","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1096\/fasebj.7.15.8262328","article-title":"Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis","volume":"7","author":"Stetler-Steveson","year":"1993","journal-title":"FASEB J"},{"key":"10.1016\/j.jaad.2005.10.004_bib19","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1600-0765.1983.tb00388.x","article-title":"Minocycline reduces gingival collagenolytic activity during diabetes: preliminary observations and a proposed new mechanism of action","volume":"18","author":"Golub","year":"1983","journal-title":"J Periodont Res"},{"key":"10.1016\/j.jaad.2005.10.004_bib20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/10454411910020030201","article-title":"Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs","volume":"2","author":"Golub","year":"1991","journal-title":"Crit Rev Oral Biol Med"},{"key":"10.1016\/j.jaad.2005.10.004_bib21","first-page":"672","article-title":"Angiogenesis inhibition by minocycline","volume":"51","author":"Tamargo","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.jaad.2005.10.004_bib22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/08959374980120010301","article-title":"Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells","volume":"12","author":"Hanemaaijer","year":"1998","journal-title":"Adv Dent Res"},{"key":"10.1016\/j.jaad.2005.10.004_bib23","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0306-4522(99)00345-0","article-title":"Reduction of post-traumatic brain injury and free radical production by inhibition of the caspase-1 cascade","volume":"94","author":"Fink","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.jaad.2005.10.004_bib24","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1084\/jem.185.5.933","article-title":"Expression of a dominant negative mutant of interleukin-1 beta converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury","volume":"185","author":"Friedlander","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaad.2005.10.004_bib25","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0306-4522(00)00173-1","article-title":"Functional role and therapeutic implications of neuronal caspase-1 and -3 in a mouse model of traumatic spinal cord injury","volume":"99","author":"Li","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.jaad.2005.10.004_bib26","doi-asserted-by":"crossref","first-page":"15769","DOI":"10.1073\/pnas.95.26.15769","article-title":"Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia","volume":"95","author":"Yrjanheikki","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaad.2005.10.004_bib27","doi-asserted-by":"crossref","first-page":"13496","DOI":"10.1073\/pnas.96.23.13496","article-title":"A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window","volume":"96","author":"Yrjanheikki","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaad.2005.10.004_bib28","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1227\/00006123-200106000-00051","article-title":"Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction","volume":"48","author":"Sanchez Mejia","year":"2001","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jaad.2005.10.004_bib29","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/77528","article-title":"Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease","volume":"6","author":"Chen","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.jaad.2005.10.004_bib30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/417074a","article-title":"Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice","volume":"417","author":"Zhu","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jaad.2005.10.004_bib31","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/art.1780351007","article-title":"Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline","volume":"35","author":"Yu","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2005.10.004_bib32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/08959374980120012401","article-title":"Effect of minocycline on osteoporosis","volume":"12","author":"Williams","year":"1998","journal-title":"Adv Dent Res"},{"key":"10.1016\/j.jaad.2005.10.004_bib33","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00002281-199605000-00013","article-title":"Potential of tetracycline to modify cartilage breakdown in osteoarthritis","volume":"8","author":"Ryan","year":"1996","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jaad.2005.10.004_bib34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/08959374980120012101","article-title":"Effects of tetracyclines on bone metabolism","volume":"12","author":"Vernillo","year":"1998","journal-title":"Adv Dent Res"},{"key":"10.1016\/j.jaad.2005.10.004_bib35","series-title":"Acne and rosacea","author":"Plewig","year":"1993"},{"key":"10.1016\/j.jaad.2005.10.004_bib36","first-page":"118","article-title":"A status report on the use of subantimicrobial-dose doxycycline. A review of the biologic and antimicrobial effects of the tetracyclines","volume":"74","author":"Del Rosso","year":"2004","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2005.10.004_bib37","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1001\/archderm.1984.01650460048018","article-title":"Neutrophil chemotaxis in patients with acne receiving oral tetracycline therapy","volume":"120","author":"Esterly","year":"1984","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.10.004_bib38","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/archderm.139.4.459","article-title":"Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne","volume":"139","author":"Skidmore","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.10.004_bib39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2133.1972.tb07416.x","article-title":"Perioral dermatitis: aetiology and treatment with tetracycline","volume":"87","author":"Macdonald","year":"1972","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.10.004_bib40","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/014107689709000308","article-title":"Rosacea: classification and treatment","volume":"90","author":"Jansen","year":"1997","journal-title":"J R Soc Med"},{"key":"10.1016\/j.jaad.2005.10.004_bib41","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/0002-9394(89)90676-4","article-title":"The effect of doxycycline on ocular rosacea","volume":"107","author":"Frucht-Pery","year":"1989","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jaad.2005.10.004_bib42","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/archderm.1994.01690030091015","article-title":"Rosacea\u2014pathophysiology and treatment","volume":"130","author":"Wilkin","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.10.004_bib43","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/archderm.1986.01660180076019","article-title":"The treatment of bullous pemphigoid successfully controlled by tetracycline and nicotinamide. A preliminary report","volume":"122","author":"Beck","year":"1986","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.10.004_bib44","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0190-9622(08)80585-3","article-title":"Linear IgA bullous dermatosis: successful treatment with tetracyclines and nicotinamide","volume":"26","author":"Peoples","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.10.004_bib45","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0190-9622(08)80651-2","article-title":"Treatment of pemphigus and linear IgA dermatosis with nicotinamide and tetracycline: a review of 13 cases","volume":"28","author":"Chaffins","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.10.004_bib46","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archderm.1994.01690060083010","article-title":"Nicotinamide and tetracycline therapy of bullous pemphigoid","volume":"130","author":"Fivenson","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.10.004_bib47","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1365-2133.1995.tb00727.x","article-title":"Minimizing cicatricial pemphigoid orodynia with minocycline","volume":"132","author":"Poskitt","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.10.004_bib48","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1365-2133.1995.tb02498.x","article-title":"Bullous pemphigoid successfully controlled by tetracycline and nicotinamide","volume":"133","author":"Kolbach","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.10.004_bib49","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0190-9622(97)70260-3","article-title":"Lichen planus pemphigoides: combination therapy with tetracycline and nicotinamide","volume":"36","author":"Fivenson","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.10.004_bib50","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1046\/j.1365-2133.1999.02996.x","article-title":"Sublamina densa-type linear IgA bullous dermatosis successfully treated with oral tetracycline and niacinamide","volume":"141","author":"Yomoda","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.10.004_bib51","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0738-081X(00)00189-9","article-title":"Treatment of subepidermal immunobullous diseases","volume":"19","author":"Wojnarowska","year":"2001","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2005.10.004_bib52","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1046\/j.1365-2230.2001.00838.x","article-title":"Minocycline as a therapeutic option in bullous pemphigoid","volume":"26","author":"Loo","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2005.10.004_bib53","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0738-081X(00)00187-5","article-title":"Tetracycline and niacinamide in the treatment of blistering skin diseases","volume":"19","author":"Chaidemenos GCh","year":"2001","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2005.10.004_bib54","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/archderm.137.1.69","article-title":"The use of tetracyclines for the treatment of sarcoidosis","volume":"137","author":"Bachelez","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.10.004_bib55","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1001\/archderm.1994.01690060078008","article-title":"Inhibition of a model of in vitro granuloma formation by tetracyclines and ciprofloxacin","volume":"130","author":"Webster","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2005.10.004_bib56","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1046\/j.1365-2133.1999.02853.x","article-title":"Minocycline for the treatment of cutaneous silicone granulomas","volume":"140","author":"Senet","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.10.004_bib57","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000247454","article-title":"Minocycline in granulomatous cheilitis: experience with 6 cases","volume":"185","author":"Veller Fornasa","year":"1992","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2005.10.004_bib58","first-page":"153","article-title":"Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study","volume":"20","author":"Cianfrocca","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2005.10.004_bib59","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/09546638909086683","article-title":"The successful use of minocycline in pyoderma gangrenosum-a report of seven cases and review of the literature","volume":"1","author":"Berth-Jones","year":"1989","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.jaad.2005.10.004_bib60","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0190-9622(98)70272-5","article-title":"Topical clindamycin versus systemic tetracycline in hidradenitis suppurativa","volume":"39","author":"Jemec","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2005.10.004_bib61","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000247696","article-title":"Cutaneous manifestations of neutrophilic disease","volume":"183","author":"Vignon-Pennamen","year":"1991","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaad.2005.10.004_bib62","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1365-2133.1993.tb00242.x","article-title":"Successful treatment of Sweet's syndrome with doxycycline","volume":"128","author":"Joshi","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.10.004_bib63","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2340\/0001555571189194","article-title":"Use of anti-collagenase properties of doxycycline in treatment of alpha 1-antitrypsin deficiency panniculitis","volume":"71","author":"Humbert","year":"1991","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2005.10.004_bib64","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2133.1974.tb12902.x","article-title":"Tetracycline for the treatment of pityriasis lichenoides","volume":"91","author":"Piamphongsan","year":"1974","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2005.10.004_bib65","doi-asserted-by":"crossref","first-page":"31504","DOI":"10.1074\/jbc.272.50.31504","article-title":"Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-\u03b1 and doxycycline","volume":"272","author":"Hanemaaijer","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaad.2005.10.004_bib66","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1006\/cimm.1996.0027","article-title":"The effect of minocycline in rat models of inflammatory arthritis: correlation of arthritis suppression with enhanced T-cell calcium flux","volume":"167","author":"Sewell","year":"1996","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jaad.2005.10.004_bib67","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1365-2249.1995.tb03864.x","article-title":"The influence of tetracyclines on T cell activation","volume":"102","author":"Kloppenburg","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaad.2005.10.004_bib68","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/0003-4819-122-2-199501150-00001","article-title":"Trial Group. Minocycline in rheumatoid arthritis: a 48 week double-blind placebo controlled trial","volume":"122","author":"Tilley","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2005.10.004_bib69","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1002\/1529-0131(200110)44:10<2235::AID-ART385>3.0.CO;2-A","article-title":"Treatment of early seropositive rheumatoid arthritis: a two-year double-blind comparison of minocycline and hydroxychloroquine","volume":"44","author":"O'Dell","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaad.2005.10.004_bib70","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(05)79828-7","article-title":"Minocycline in early diffuse scleroderma","volume":"352","author":"Le","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2005.10.004_bib71","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1096\/fasebj.13.8.781","article-title":"Regulation of matrix metalloproteinase expression in tumor invasion","volume":"13","author":"Westermarck","year":"1999","journal-title":"FASEB J"},{"key":"10.1016\/j.jaad.2005.10.004_bib72","first-page":"312","article-title":"Use of tetracycline as an inhibitor of matrix metalloproteinase activity secreted by human bone-metastasizing cancer cells","volume":"17","author":"Duivenvoorden","year":"1997","journal-title":"Invasion Metastasis"},{"key":"10.1016\/j.jaad.2005.10.004_bib73","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/jnci\/93.3.178","article-title":"Development of matrix metalloproteinase inhibitors in cancer therapy","volume":"93","author":"Hidalgo","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jaad.2005.10.004_bib74","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ijc.10168","article-title":"Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancel model","volume":"98","author":"Lokeshwar","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2005.10.004_bib75","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1067\/mlc.2001.116591","article-title":"Inhibition of mesothelioma cell growth in vitro by doxycycline","volume":"138","author":"Rubins","year":"2001","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jaad.2005.10.004_bib76","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1200\/JCO.2001.19.2.584","article-title":"Phase I clinical trail of oral COL-3, a matrix metalloproteinase inhibitor in patients with refractory metastatic cancer","volume":"19","author":"Rudek","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2005.10.004_bib77","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1749-6632.1999.tb07682.x","article-title":"MMP inhibition in abdominal aortic aneurysms","volume":"878","author":"Thompson","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaad.2005.10.004_bib78","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1067\/mva.2001.117891","article-title":"Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized double-blind, placebo-controlled pilot study","volume":"34","author":"Mosorin","year":"2001","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jaad.2005.10.004_bib79","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/jac\/49.2.411","article-title":"Modulation of oxidative burst of neutrophils by doxycycline in patients with acute myocardial infarction","volume":"49","author":"Takeshita","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jaad.2005.10.004_bib80","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1177\/00220345000790120801","article-title":"The in vivo expression of the collagenolytic matrix metalloproteinase (MMP-2, -8, -13 and -14) and matrilysin (MMP-7) in adult and localized juvenile periodontitis","volume":"79","author":"Tervahartiala","year":"2000","journal-title":"J Dent Res"},{"key":"10.1016\/j.jaad.2005.10.004_bib81","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1902\/jop.2002.73.1.79","article-title":"Inhibition of proteolytic serpinolytic and progelatinase-b activation activities of periodontopathogens by doxycycline and the non-antimicrobial chemically modified tetracycline derivatives","volume":"73","author":"Grenier","year":"2002","journal-title":"J Periodontol"},{"key":"10.1016\/j.jaad.2005.10.004_bib82","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1600-0765.1984.tb01334.x","article-title":"Tetracyclines inhibit tissue collagenase activity: a new mechanism in the treatment of periodontal disease","volume":"19","author":"Golub","year":"1984","journal-title":"J Periodont Res"},{"key":"10.1016\/j.jaad.2005.10.004_bib83","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/08959374980120011501","article-title":"Safety and efficacy of sub-antimicrobial dose doxycycline therapy in patients with adult periodontitis","volume":"12","author":"Ciancio","year":"1998","journal-title":"Adv Dent Res"},{"key":"10.1016\/j.jaad.2005.10.004_bib84","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1034\/j.1600-051X.2001.280806.x","article-title":"Utilization of locally delivered doxycycline in non-surgical treatment of chronic adult periodontitis: a comparative multi-center trial of 2 treatment approaches","volume":"28","author":"Wennstrom","year":"2001","journal-title":"J Clin Periodontol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962205032317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962205032317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:40:07Z","timestamp":1759268407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962205032317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0190962205032317"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2005.10.004","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tetracyclines: Nonantibiotic properties and their clinical implications","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2005.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}